18.08.2014 18:18:36
|
Tecogen Appoints David Garrison As New CFO - Quick Facts
(RTTNews) - Tecogen Inc. (TGEN) announced that it has appointed David Garrison as its new Chief Financial Officer or CFO.
The company stated that Garrison brought expertise in publicly traded companies to the Tecogen management team including assisting the company with its listing on the NASDAQ.
Tecogen noted that most recently, Garrison served as Chief Financial Officer of Arrhythmia Research Technology, Inc., a NYSE-listed contract medical device manufacturer focusing on products related to cardiology and orthopedics. During his tenure, Garrison led the finance team through multiple acquisitions, while tripling the size of the company.
Other experience includes leading the finance department in a consumer products company and construction experience in an environmental services company, the company said.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Targeted Genetics Corp.mehr Nachrichten
Keine Nachrichten verfügbar. |